CoChat

Oncofetal gene SALL4 and prognosis in cancer: A systematic review with meta-analysis

Open access
Nicolè, Lorenzo, Sanavia, Tiziana, Veronese, Nicola, Cappellesso, Rocco, Luchini, Claudio, Dabrilli, Paolo, Fassina, Ambrogio · 2017 · Oncotarget
Cited by 39

The DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.

Abstract

// Lorenzo Nicolè 1, * , Tiziana Sanavia 2, * , Nicola Veronese 3 , Rocco Cappellesso 1, 7 , Claudio Luchini 4, 5, 6 , Paolo Dabrilli 1 , Ambrogio Fassina 1 1 Department of Medicine, Surgical Pathology & Cytopathology Unit, University of Padova, Padova, Italy 2 Department of Biomedical Informatics, Harvard Medical School, Boston, MA, USA 3 National Research Council, Neuroscience Institute, Aging Branch, Padova, Italy 4 Department of Pathology and Diagnostics, University and Hospital Trust of Verona, Verona, Italy 5 ARC-NET Research Center, University and Hospital Trust of Verona, Verona, Italy 6 Department of Pathology, Santa Chiara Hospital, Trento, Italy 7 Pathological Anatomy and Histology Unit, Veneto Institute of Oncology, Padova, Italy * These authors have contributed equally to this work Correspondence to: Ambrogio Fassina, email: ambrogio.fassina@unipd.it Keywords: SALL4, cancer, prognosis, meta-analysis, targeted therapy Received: April 05, 2016 Accepted: January 06, 2017 Published: February 01, 2017 ABSTRACT The Spalt-Like Transcription Factor 4 (SALL4) oncogene plays a central function in embryo-fetal development and is absent in differentiated tissues. Evidence suggests that it can be reactivated in several cancers worsening the prognosis. We aimed at investigating the risk associated with SALL4 reactivation for all-cause mortality and recurrence in cancer using the current literature. A PubMed and SCOPUS search until 1st September 2016 was performed, focusing on perspective studies reporting prognostic parameters in cancer data. In addition, 17 datasets of different cancer types from The Cancer Genome Atlas were considered. A total of 9,947 participants across 40 cohorts, followed-up for about 5 years on average, were analyzed comparing patients showing SALL4 presence (SALL4+, n = 1,811) or absence (SALL4-, n = 8,136). All data were summarised using risk ratios (RRs) for the number of deaths/recurrences and hazard ratios (HRs) for the time-dependent risk related to SALL4+, adjusted for potential confounders. SALL4+ significantly increased overall mortality (RR = 1.34, 95% confidence intervals (CI)=1.21-1.48, p<0.0001, I 2 =66%; HR=1.4; 95%CI: 1.19-1.65; p<0.0001; I 2 =63%) and recurrence of disease (RR = 1.25, 95% CI = 1.1-1.42, p=0.0006, I 2 =62%); HR=1.52; 95% CI: 1.22-1.89, p=0.0002; I 2 =69%) compared to SALL4-. Moreover, SALL4 remained significantly associated with poor prognosis even using HRs adjusted for potential confounders (overall mortality: HR=1.4; 95%CI: 1.19-1.65; p<0.0001; I 2 =63%; recurrence of disease: HR=1.52; 95% CI: 1.22-1.89, p=0.0002; I 2 =69%). These results suggest that SALL4 expression increases both mortality and recurrence of cancer, confirming this gene as an important prognostic marker and a potential target for personalized medicine.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.18632/oncotarget.14952

Cites

13 of 13 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 13 references

Cited by

See all 39

Metadata

Authors
Nicolè, L., Sanavia, T., Veronese, N., Cappellesso, R., Luchini, C., Dabrilli, P., & Fassina, A.
Venue
Oncotarget
Published
2017-02-01
Volume
8
Issue
14
Pages
22968-22979
ISSN
1949-2553 (ISSN-L)
OpenAlex
W2583443690
Cited by
39
References
13
FWCI
0.76
Type
journal article
Language
en
Open access
diamond

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Oncofetal gene SALL4 and prognosis in cancer: A systematic review with meta-analysis. https://app.cochat.ai/papers/10.18632/oncotarget.14952
The paper
Nicolè, L., Sanavia, T., Veronese, N., Cappellesso, R., Luchini, C., Dabrilli, P., & Fassina, A. (2017). Oncofetal gene SALL4 and prognosis in cancer: A systematic review with meta-analysis. Oncotarget. https://doi.org/10.18632/oncotarget.14952

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.